πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 81 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11040998

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11021468

TGF-ß inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10966977

Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor

TG Therapeutics, Inc. Β· Granted Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10968249

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10869863

Multi-arm polymeric targeting anti-cancer conjugate

BrightGene Bio-Medical Technology Co., Ltd. Β· Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10858335

2,3-Disubstituted pyridine compounds as TGF-Ξ² inhibitors and methods of use

Rigel Pharmaceuticals, Inc. Β· Granted Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10822337

TGF-Ξ² inhibitorC

Rigel Pharmaceuticals, Inc. Β· Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10759905

Biodegradable amphiphilic polymer, polymeric vesicles prepared therefrom, and application

BrightGene Bio-Medical Technology Co., Ltd. Β· Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10729768

Combination of anti-CD20 antibody and PI3 kinase selective inhibitor

TG Therapeutics, Inc. Β· Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10696693

Fused imidazole derivatives as TGF-beta inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10696713

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10689413

Composition enriched in single isomer of NUC-1031 and preparation method and use thereof

BrightGene Bio-Medical Technology Co., Ltd. Β· Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10683347

Treatment of cancer using anti-TGF-Ξ² and anti-PD-1 antibodies

The Regents of the University of California Β· Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10654834

Non-systemic TGR5 agonists

VENENUM BIODESIGN, LLC Β· Granted Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10548883

Benzotriazole-derived Ξ± and Ξ²-unsaturated amide compound used as TGF-Ξ² RI inhibitor

Medshine Discovery Inc. Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10519191

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10457703

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10376515

Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activati

Northwestern University Β· Granted Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10322125

TGF-beta enhancing compositions for cartilage repair and methods related thereto

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10323061

Heteroaryl containing bile acid analogs as FXR/TGR5 agonists and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10292940

Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof

BrightGene Bio-Medical Technology Co., Ltd. Β· Granted Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10287295

TGF-Ξ² inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10266560

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10246483

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted